Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma.

Saved in:
Bibliographic Details
Title: Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma.
Authors: Niesvizky, Ruben1 (AUTHOR) run9001@med.cornell.edu, Martínez-Baños, Déborah1 (AUTHOR), Jalbrzikowski, Jessica1 (AUTHOR), Christos, Paul2 (AUTHOR), Furst, Jessica1 (AUTHOR), De Sancho, Maria1 (AUTHOR), Mark, Tomer1 (AUTHOR), Pearse, Roger1 (AUTHOR), Mazumdar, Madhu2 (AUTHOR), Zafar, Faiza1 (AUTHOR), Pekle, Karen1 (AUTHOR), Leonard, John1 (AUTHOR), Jayabalan, David1 (AUTHOR), Coleman, Morton1 (AUTHOR)
Source: Leukemia & Lymphoma. Dec2007, Vol. 48 Issue 12, p2330-2337. 8p. 6 Charts, 1 Graph.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428190701647887